Cyanosis in a Patient with AIDS

Last updated March 26, 2015
Case Authors: 
Brian R. Wood, MD
Assistant Professor of Medicine
Division of Infectious Diseases
University of Washington School of Medicine
David H. Spach, MD's picture
David H. Spach, MD
Professor of Medicine
Division of Infectious Diseases
Clinical Director, Mountain West AIDS Education and Training Center
University of Washington School of Medicine
Learning Objectives: 
  1. Understand the common causes of methemoglobinemia.
  2. List the appropriate treatment for methemoglobinemia.

Display Group

  1. Zosel A, Rychter K, Leikin JB. Dapsone-induced methemoglobinemia: case report and literature review. Am J Ther. 2007;14:585-7.
  2. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34:646-56.
  3. Turner MD, Karlis V, Glickman RS. The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report. Anesth Prog. 2007 Fall;54:115-7.
  4. Rehman HU. Methemoglobinemia. West J Med. 2001;175:193-6.
  5. Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore). 2004;83:265-73.
  6. Gallant JE, Hoehn-Saric E, Smith MD. Respiratory insufficiency from dapsone-induced methemoglobinemia. AIDS. 1991;5:1392-3.
  7. Prasad R, Singh R, Mishra OP, Pandey M. Dapsone induced methemoglobinemia : Intermittent vs continuous intravenous methylene blue therapy. Indian J Pediatr. 2008;75:245-7.
  8. Williams S, MacDonald P, Hoyer JD, Barr RD, Athale UH. Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome b5 reductase (Cb5R) enzyme levels. Pediatr Blood Cancer. 2005;44:55-62.
  9. Sin DD, Shafran SD. Dapsone- and primaquine-induced methemoglobinemia in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:477-81.
  10. Coleman MD, Rhodes LE, Scott AK, et al. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. Br J Clin Pharmacol. 1992;34:244-9.
  11. Coleman MD, Scott AK, Breckenridge AM, Park BK. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man. Br J Clin Pharmacol. 1990;30:761-7.